Soluble B7-H5 Is a Novel Diagnostic, Severity, and Prognosis Marker in Acute Pancreatitis
Levels of sB7-H5 were increased in AP patients. (a) Levels of sB7-H5 were significantly increased in AP patients and decreased in abdominal pain patients (PP) when compared with healthy controls (HC). (b) Levels of sB7-H5 of AP patients at 72 hours after admission were significantly increased than those on admission. .
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.